DONATE

LUMIRIS, the IBEC spin-off that has raised €6 million to transform assisted reproduction

This spin-off from the Institute for Bioengineering of Catalonia has developed a non-invasive technology that analyses the metabolism of human embryos to select the most suitable ones for implantation. This innovation promises to significantly reduce the time and number of treatment cycles required for in vitro fertilisation. The success of LUMIRIS’ technology has led to a new round of investment of €1.5 million, bringing the total to €6 million since the company was founded in 2023.

IBEC and SJD Barcelona Children’s Hospital strengthen their collaboration with a day of translational innovation

The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.

7th edition of the ‘Mad for Bioengineering’ course successfully completed

For the seventh consecutive year, IBEC, with the support of the Catalunya La Pedrera Foundation, has successfully run its ‘Mad for Bioengineering’ course. Aimed at first-year students interested in STEM careers, the programme offers a unique immersion into the world of bioengineering, tackling health problems from a multidisciplinary perspective. The closing ceremony, attended by the students and their families, focused on the presentation of the final projects and the awarding of diplomas.

IBEC scientist César Rodriguez-Emmenegger awarded prestigious ERC Consolidator Grant

IBEC’s Principal Investigator César Rodriguez-Emmenegger has been awarded an ERC Consolidator Grant. This prestigious European funding supports scientists in the consolidation phase of their research teams, allowing them to pursue innovative scientific ideas. The €2 million over five years will allow Rodriguez-Emmenegger and his team to develop Phagocytic Synthetic Cells (PSCs) to fight antibiotic-resistant pathogens.

IBEC and VHIR hold a collaboration day to promote synergies

The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.

IBEC’s transdisciplinary projects at the S+T+ARTS Symposium on Art, Science and Technology

The S+T+ARTS Symposium: Exploring the intersections of Arts, Science, Technology and Society as catalysts for change took place on 29-30 October. There, Teresa Sanchis, IBEC’s Head of Strategy, had the opportunity to explain the Institute’s Arts and Science programme and discuss the importance of effective intermediaries and metrics for measuring the impact of projects that combine creativity and scientific innovation.

Three IBEC researchers selected in the CaixaResearch 2024 call to lead health research projects

IBEC researchers Benedetta Bolognesi, Xavier Fernàndez Busquets and Xavier Trepat have been selected in the CaixaResearch 2024 call to lead their own research projects. The grants will provide financial support for the scientists to carry out their research in key areas such as cancer, malaria and amyotrophic lateral sclerosis.

Advances in nanobiotechnology and nanomedicine explored at the 12th International NanoBio&Med Conference

The latest developments in nanotechnology, biotechnology and medicine were presented at the NanoBio&Med 2024 International Conference, held this week at the Barcelona Science Park (PCB) from 5 to 7 November. This is an annual event designed to establish new collaborations and promote innovative projects in the scientific-industrial sector.